1
|
Ceccarelli M, Berretta M, Venanzi Rullo E,
Nunnari G and Cacopardo B: ‘Differences and similarities between
Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and
SARS-CoV-2. Would a rose by another name smell as sweet?’. Eur Rev
Med Pharmacol Sci. 24:2781–2783. 2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Vella F, Senia P, Ceccarelli M, Vitale E,
Maltezou H, Taibi R, Lleshi A, Venanzi Rullo E, Pellicanò GF,
Rapisarda V, et al: Transmission mode associated with coronavirus
disease 2019: A review. Eur Rev Med Pharmacol Sci. 24:7889–7904.
2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Pavone P, Ceccarelli M, Marino S, Caruso
D, Falsaperla R, Berretta M, Rullo EV and Nunnari G: SARS-CoV-2
related paediatric acute-onset neuropsychiatric syndrome. Lancet
Child Adolesc Health. 5:e19–e21. 2021.PubMed/NCBI View Article : Google Scholar
|
4
|
Meduri A, Oliverio GW, Mancuso G,
Giuffrida A, Guarneri C, Venanzi Rullo E, Nunnari G and Aragona P:
Ocular surface manifestation of COVID-19 and tear film analysis.
Sci Rep. 10(20178)2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Guarneri C, Rullo EV, Pavone P, Berretta
M, Ceccarelli M, Natale A and Nunnari G: Silent COVID-19: What your
skin can reveal. Lancet Infect Dis. 21:24–25. 2021.PubMed/NCBI View Article : Google Scholar
|
6
|
Pirisi M, Rigamonti C, D'Alfonso S,
Nebuloni M, Fanni D, Gerosa C, Orrù G, Venanzi Rullo E, Pavone P,
Faa G, et al: Liver infection and COVID-19: The electron microscopy
proof and revision of the literature. Eur Rev Med Pharmacol Sci.
25:2146–2151. 2021.PubMed/NCBI View Article : Google Scholar
|
7
|
Guarneri C, Venanzi Rullo E, Gallizzi R,
Ceccarelli M, Cannavò S and Nunnari G: Diversity of clinical
appearance of cutaneous manifestations in the course of COVID-19. J
Eur Acad Dermatol Venereol. 34:e449–e450. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Ceccarelli M, Marino A, Cosentino F,
Moscatt V, Celesia BM, Gussio M, Bruno R, Rullo EV, Nunnari G and
Cacopardo BS: Post-infectious ST elevation myocardial infarction
following a COVID-19 infection: A case report. Biomed Rep.
16(10)2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Lassandro G, Palladino V, Palmieri VV,
Amoruso A, Del Vecchio GC and Giordano P: Covid-19 and children
with immune thrombocytopenia: Emerging issues. Mediterr J Hematol
Infect Dis. 12(e2020028)2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Lai A, Bergna A, Menzo S, Zehender G,
Caucci S, Ghisetti V, Rizzo F, Maggi F, Cerutti F, Giurato G, et
al: Circulating SARS-CoV-2 variants in Italy, October 2020-March
2021. Virol J. 18(168)2021.PubMed/NCBI View Article : Google Scholar
|
11
|
Lai A, Bergna A, Caucci S, Clementi N,
Vicenti I, Dragoni F, Cattelan AM, Menzo S, Pan A, Callegaro A, et
al: Molecular Tracing of SARS-CoV-2 in Italy in the first three
months of the epidemic. Viruses. 12(798)2020.PubMed/NCBI View Article : Google Scholar
|
12
|
Marietta M, Ageno W, Artoni A, De Candia
E, Gresele P, Marchetti M, Marcucci R and Tripodi A: COVID-19 and
haemostasis: A position paper from Italian Society on Thrombosis
and Haemostasis (SISET). Blood Transfus. 18:167–169.
2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Hill A and Hill AQA: Autoimmune hemolytic
anemia. Hematology Am Soc Hematol Educ Program. 2018:382–389.
2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Longhitano E, Nardi C, Calabrese V,
Messina R, Mazzeo G, Venanzi Rullo E, Ceccarelli M, Chatrenet A,
Saulnier P, Torreggiani M, et al: Hypernatraemia and low eGFR at
hospitalization in COVID-19 patients: A deadly combination. Clin
Kidney J. 14:2227–2233. 2021.PubMed/NCBI View Article : Google Scholar
|
15
|
Buccafusca M, Micali C, Autunno M, Versace
AG, Nunnari G and Musumeci O: Favourable course in a cohort of
Parkinson's disease patients infected by SARS-CoV-2: A
single-centre experience. Neurol Sci. 42:811–816. 2021.PubMed/NCBI View Article : Google Scholar
|
16
|
Kruhonja Galic Z, Jagnjic S,
Bingulac-Popovic J, Planinc Peraica A, Hecimovic A, Strauss Patko M
and Jukic I: Warm red blood cell autoantibodies and clinical
diagnoses in patients with or without autoimmune hemolysis.
Transfus Clin Biol. 27:25–29. 2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Ceccarelli M, Venanzi Rullo E and Nunnari
G: Risk factors of venous thrombo-embolism during cytomegalovirus
infection in immunocompetent individuals. A systematic review. Eur
J Clin Microbiol Infect Dis. 37:381–390. 2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Brodsky RA: Warm Autoimmune Hemolytic
Anemia. N Engl J Med. 381:647–654. 2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Bonaccorsi I, Carrega P, Venanzi Rullo E,
Ducatelli R, Falco M, Freni J, Miceli M, Cavaliere R, Fontana V,
Versace A, et al: HLA-C*17 in COVID-19 patients: Hints for
associations with severe clinical outcome and cardiovascular risk.
Immunol Lett. 234:44–46. 2021.PubMed/NCBI View Article : Google Scholar
|
20
|
Novelli L, Motta F, De Santis M, Ansari
AA, Gershwin ME and Selmi C: The JANUS of chronic inflammatory and
autoimmune diseases onset during COVID-19-A systematic review of
the literature. J Autoimmun. 117(102592)2021.PubMed/NCBI View Article : Google Scholar
|
21
|
Angileri F, Légaré S, Marino Gammazza A,
Conway de Macario E, Macario AJL and Cappello F: Is molecular
mimicry the culprit in the autoimmune haemolytic anaemia affecting
patients with COVID-19? Br J Haematol. 190:e92–e93. 2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Barcellini W, Giannotta JA and Fattizzo B:
Are patients with autoimmune cytopenias at higher Risk of COVID-19
Pneumonia? The experience of a reference center in Northern Italy
and review of the literature. Front Immunol.
11(609198)2020.PubMed/NCBI View Article : Google Scholar
|
23
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
24
|
Pelle MC, Tassone B, Ricchio M, Mazzitelli
M, Davoli C, Procopio G, Cancelliere A, La Gamba V, Lio E, Matera
G, et al: Late-onset myocardial infarction and autoimmune
haemolytic anaemia in a COVID-19 patient without respiratory
symptoms, concomitant with a paradoxical increase in inflammatory
markers: A case report. J Med Case Rep. 14(246)2020.PubMed/NCBI View Article : Google Scholar
|
25
|
Bader F, Manla Y, Atallah B and Starling
RC: Heart failure and COVID-19. Heart Fail Rev. 26:1–10.
2021.PubMed/NCBI View Article : Google Scholar
|
26
|
Maslov DV, Simenson V, Jain S and Badari
A: COVID-19 and cold agglutinin hemolytic anemia. s TH Open.
04:e175–e177. 2020.PubMed/NCBI View Article : Google Scholar
|
27
|
Algassim AA, Elghazaly AA, Alnahdi AS,
Mohammed-Rahim OM, Alanazi AG, Aldhuwayhi NA, Alanazi MM, Almutairi
MF, Aldeailej IM, Kamli NA and Aljurf MD: Prognostic significance
of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2
infection, Ann. Hematol. 100:37–43. 2021.PubMed/NCBI View Article : Google Scholar
|
28
|
Liput JR, Jordan K, Patadia R and Kander
E: Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic
SARS-CoV-2 Infection. Cureus. 13(e14101)2021.PubMed/NCBI View Article : Google Scholar
|
29
|
Bass GF, Tuscano ET and Tuscano JM:
Diagnosis and classification of autoimmune hemolytic anemia.
Autoimmun Rev. 13:560–564. 2014.PubMed/NCBI View Article : Google Scholar
|
30
|
Berentsen S, Randen U and Tjønnfjord GE:
Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol
Clin North Am. 29:455–471. 2015.PubMed/NCBI View Article : Google Scholar
|
31
|
Audia S, Grienay N, Mounier M, Michel M
and Bonnotte B: Evans' Syndrome: From diagnosis to treatment. J
Clin Med. 9(3851)2020.PubMed/NCBI View Article : Google Scholar
|
32
|
Kalfa TA: Warm antibody autoimmune
hemolytic anemia. Hematology Am Soc Hematol Educ Program.
2016:690–697. 2016.PubMed/NCBI View Article : Google Scholar
|
33
|
Taherifard E, Taherifard E, Movahed H and
Mousavi MR: Hematologic autoimmune disorders in the course of
COVID-19: A systematic review of reported cases. Hematology.
26:225–239. 2021.PubMed/NCBI View Article : Google Scholar
|
34
|
Zama D, Pancaldi L, Baccelli F, Guida F,
Gottardi F, Dentale N, Esposito F, Masetti R, Viale P and Pession
A: Autoimmune hemolytic anemia in children with COVID-19. Pediatr
Blood Cancer. 69(e29330)2022.PubMed/NCBI View Article : Google Scholar
|
35
|
Ahmed Y, Khandelwal A and Walker L: Cold
agglutinin disease and COVID-19 requiring therapeutic plasma
exchange. BMJ Case Rep. 14(e244227)2021.PubMed/NCBI View Article : Google Scholar
|
36
|
Moonla C, Watanaboonyongcharoen P,
Suwanpimolkul G, Paitoonpong L, Jantarabenjakul W, Chanswangphuwana
C, Polprasert C, Rojnuckarin P and Putcharoen O: Cold agglutinin
disease following SARS-CoV-2 and Mycoplasma pneumoniae
co-infections. Clin Case Rep. 8:2402–2405. 2020.PubMed/NCBI View Article : Google Scholar
|
37
|
Raghuwanshi B: Serological blood group
discrepancy and cold agglutinin autoimmune hemolytic anemia
associated with novel coronavirus. Cureus.
12(e11495)2020.PubMed/NCBI View Article : Google Scholar
|
38
|
Jacobs J and Eichbaum Q: COVID-19
associated with severe autoimmune hemolytic anemia. Transfusion.
61:635–640. 2021.PubMed/NCBI View Article : Google Scholar
|
39
|
Zagorski E, Pawar T, Rahimian S and Forman
D: Cold agglutinin autoimmune haemolytic anaemia associated with
novel coronavirus (COVID-19). Br J Haematol. 190:e183–e184.
2020.PubMed/NCBI View Article : Google Scholar
|
40
|
Capes A, Bailly S, Hantson P, Gerard L and
Laterre PF: COVID-19 infection associated with autoimmune hemolytic
anemia. Ann Hematol. 99:1679–1680. 2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Kaur J, Mogulla S, Khan R, Krishnamoorthy
G and Garg S: Transient Cold Agglutinins in a Patient With
COVID-19. Cureus. 13(e12751)2021.PubMed/NCBI View Article : Google Scholar
|
42
|
Patil NR, Herc ES and Girgis M: Cold
agglutinin disease and autoimmune hemolytic anemia with pulmonary
embolism as a presentation of COVID-19 infection. Hematol Oncol
Stem Cell Ther. 15:213–216. 2022.PubMed/NCBI View Article : Google Scholar
|
43
|
D'Aloisio R, Nasillo V, Gironi M and
Mastropasqua R: Bilateral macular hemorrhage in a patient with
COVID-19. Am J Ophthalmol Case Rep. 20(100958)2020.PubMed/NCBI View Article : Google Scholar
|
44
|
Huscenot T, Galland J, Ouvrat M, Rossignol
M, Mouly S and Sène D: APHP Lariboisière COVID Group.
SARS-CoV-2-associated cold agglutinin disease: A report of two
cases. Ann Hematol. 99:1943–1944. 2020.PubMed/NCBI View Article : Google Scholar
|
45
|
Gupta R, Singh S, Anusim N, Gupta S, Gupta
S, Huben M, Howard G and Jaiyesimi I: Coronavirus Disease 2019 and
Cold Agglutinin Syndrome: An Interesting Case. Eur J Case Rep
Intern Med. 8(002387)2021.PubMed/NCBI View Article : Google Scholar
|
46
|
Nair LJ, Regukumar A and Baalamurugan KT:
COVID-19-Associated severe autoimmune hemolytic anemia: A rare case
report. Saudi J Med Med Sci. 9:276–279. 2021.PubMed/NCBI View Article : Google Scholar
|
47
|
Hindilerden F, Yonal-Hindilerden I, Akar
E, Yesilbag Z and Kart-Yasar K: Severe Autoimmune Hemolytic Anemia
in COVID-19 infection, safely treated with steroids. Mediterr J
Hematol Infect Dis. 12(e2020053)2020.PubMed/NCBI View Article : Google Scholar
|
48
|
Lazarian G, Quinquenel A, Bellal M,
Siavellis J, Jacquy C, Re D, Merabet F, Mekinian A, Braun T, Damaj
G, et al: Autoimmune haemolytic anaemia associated with COVID-19
infection. Br J Haematol. 190:29–31. 2020.PubMed/NCBI View Article : Google Scholar
|
49
|
Brazel D, Eid T and Harding C: Warm and
cold autoimmune hemolytic anemia in the setting of COVID-19
Disease. Cureus. 13(e18127)2021.PubMed/NCBI View Article : Google Scholar
|
50
|
Rosenzweig JD, McThenia SS and Kaicker S:
SARS-CoV-2 infection in two pediatric patients with immune
cytopenias: A single institution sexperience during the pandemic.
Pediatr Blood Cancer. 67(e28503)2020.PubMed/NCBI View Article : Google Scholar
|
51
|
Al-Mashdali AF, Ata YM and Yassin MA:
Concomitant autoimmune hemolytic anemia and pulmonary embolism
associated with mild COVID-19: A case report. Clin Case Rep.
9(e04952)2021.PubMed/NCBI View Article : Google Scholar
|
52
|
Mausoleo A, Henriquez S, Goujard C,
Roque-Afonso AM, Noel N and Lambotte O: Severe IgA-mediated
autoimmune hemolytic anemia triggered by SARS-CoV-2 infection. Leuk
Lymphoma. 62:2037–2039. 2021.PubMed/NCBI View Article : Google Scholar
|
53
|
Huda Z and Jahangir A, Sahra S, Rafay Khan
Niazi M, Anwar S, Glaser A and Jahangir A: A Case of
COVID-19-Associated autoimmune hemolytic anemia with
hyperferritinemia in an immunocompetent host. Cureus.
13(e16078)2021.PubMed/NCBI View Article : Google Scholar
|
54
|
Georgy JT, Jayakaran JAJ, Jacob AS,
Gunasekaran K, Korula PJ, Devasia AJ and Iyadurai R: Evans syndrome
and immune thrombocytopenia in two patients with COVID-19. J Med
Virol. 93:2642–2644. 2021.PubMed/NCBI View Article : Google Scholar
|
55
|
Jawed M, Hart E and Saeed M: Haemolytic
anaemia: A consequence of COVID-19. BMJ Case Rep.
13(e238118)2020.PubMed/NCBI View Article : Google Scholar
|
56
|
Lopez C, Kim J, Pandey A, Huang T and
DeLoughery TG: Simultaneous onset of COVID-19 and autoimmune
haemolytic anaemia, Br J. Haematol. 190:31–32. 2020.PubMed/NCBI View Article : Google Scholar
|
57
|
Vega Hernández P, Borges Rivas Y, Ortega
Sánchez E, Marqués Cabrero A, Remedios Mateo L, Silvera Roig P,
Infante Quintanar A, Díaz-Delgado Peñas R, Sánchez Escudero V and
García-García ML: Autoimmune hemolytic anemia in a pediatric
patient with severe acute respiratory Syndrome coronavirus 2
infection. Pediatr Infect Dis J. 39(e288)2020.PubMed/NCBI View Article : Google Scholar
|
58
|
Ramos-Ruperto L, García-Pérez E,
Hernández-Maraver D, Kerguelén-Fuentes A, Viejo-Llorente A,
Robles-Marhuenda Á and Busca-Arenzana C: A 3-case series of
autoimmune haemolytic anaemia and COVID-19: Is plasma exchange an
alternative? SN Compr Clin Med. 3:1420–1423. 2021.PubMed/NCBI View Article : Google Scholar
|
59
|
Woldie IL, Brown IG, Nwadiaro NF, Patel A,
Jarrar M, Quint E, Khokhotva V, Hugel N, Winger M and Briskin A:
Autoimmune Hemolytic Anemia in a 24-Year-Old Patient With COVID-19
complicated by secondary cryptococcemia and acute necrotizing
encephalitis: A case report and review of literature. J Med Cases.
11:362–365. 2020.PubMed/NCBI View Article : Google Scholar
|
60
|
Zanella A and Barcellini W: Treatment of
autoimmune hemolytic anemias. Haematologica. 99:1547–1554.
2014.PubMed/NCBI View Article : Google Scholar
|
61
|
Jäger U, Barcellini W, Broome CM, Gertz
MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, et
al: Diagnosis and treatment of autoimmune hemolytic anemia in
adults: Recommendations from the First International Consensus
Meeting. Blood Rev. 41(100648)2020.PubMed/NCBI View Article : Google Scholar
|
62
|
Barcellini W, Zaninoni A, Giannotta JA and
Fattizzo B: New insights in autoimmune hemolytic anemia: From
pathogenesis to therapy stage 1. J Clin Med. 9(3859)2020.PubMed/NCBI View Article : Google Scholar
|
63
|
Ottaviano G, Marinoni M, Graziani S,
Sibson K, Barzaghi F, Bertolini P, Chini L, Corti P, Cancrini C,
D'Alba I, et al: Rituximab unveils hypogammaglobulinemia and
immunodeficiency in children with autoimmune cytopenia. J Allergy
Clin Immunol Pract. 8:273–282. 2020.PubMed/NCBI View Article : Google Scholar
|
64
|
Ceccarelli M, Nunnari G, Celesia BM,
Pellicanò GF, Venanzi Rullo E, Berretta M and Santi Cacopardo B:
Editorial-Coronavirus disease 2019 and people living with HIV:
clinical considerations. Eur Rev Med Pharmacol Sci. 24:7534–7539.
2020.PubMed/NCBI View Article : Google Scholar
|
65
|
Campanella E, Marino A, Ceccarelli M,
Gussio M, Cosentino F, Moscatt V and Cacopardo B: Pain crisis
management in a patient with sickle cell disease during SARS-CoV-2
infection: A case report and literature review. World Acad Sci J.
4(14)2022.
|
66
|
Barcellini W, Giannotta J and Fattizzo B:
Autoimmune hemolytic anemia in adults: Primary risk factors and
diagnostic procedures, Expert Rev. Hematol. 13:585–597.
2020.PubMed/NCBI View Article : Google Scholar
|
67
|
Ceccarelli M, Pavone P, Venanzi Rullo E
and Nunnari G: Comment on safety and efficacy of oral
lopinavir/ritonavir in pediatric patients with coronavirus disease:
A nationwide comparative analysis. Eur Rev Med Pharmacol Sci.
25:2473–2474. 2021.PubMed/NCBI View Article : Google Scholar
|
68
|
Marino A, Pampaloni A, Scuderi D,
Cosentino F, Moscatt V, Ceccarelli M and Cacopardo B: High-flow
nasal cannula oxygenation and tocilizumab administration in
patients critically ill with COVID-19: A report of three cases and
a literature review. World Acad Sci. 2(23)2020.
|
69
|
Marino A, Campanella E, Ceccarelli M,
Larocca L, Bonomo C, Micali C and Cacopardo B: Sarilumab
administration in patients with severe COVID-19: A report of four
cases and a literature review. World Acad Sci. 4(24)2022.
|
70
|
Marino A, Munafò A, Augello E, Bellanca
CM, Bonomo C, Ceccarelli M, Musso N, Cantarella G, Cacopardo B and
Bernardini R: Sarilumab Administration in COVID-19 Patients:
Literature review and considerations. Infect Dis Rep. 14:360–371.
2022.PubMed/NCBI View Article : Google Scholar
|
71
|
Cosentino F, Moscatt V, Marino A,
Pampaloni A, Scuderi D, Ceccarelli M, Benanti F, Gussio M, Larocca
L, Boscia V, et al: Clinical characteristics and predictors of
death among hospitalized patients infected with SARS-CoV-2 in
Sicily, Italy: A retrospective observational study. Biomed Rep.
16(34)2022.PubMed/NCBI View Article : Google Scholar
|